Burcon NutraScience Statistics
Total Valuation
Burcon NutraScience has a market cap or net worth of 17.81 million. The enterprise value is 21.04 million.
| Market Cap | 17.81M |
| Enterprise Value | 21.04M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.72% |
| Shares Change (QoQ) | +12.59% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 103.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.57 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.89 |
| EV / Sales | 67.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.32 |
Financial Position
The company has a current ratio of 5.63, with a Debt / Equity ratio of 187.90.
| Current Ratio | 5.63 |
| Quick Ratio | 4.72 |
| Debt / Equity | 187.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.98 |
| Interest Coverage | -16.09 |
Financial Efficiency
Return on equity (ROE) is -159.36% and return on invested capital (ROIC) is -41.47%.
| Return on Equity (ROE) | -159.36% |
| Return on Assets (ROA) | -39.22% |
| Return on Capital (ROIC) | -41.47% |
| Revenue Per Employee | 12,303 |
| Profits Per Employee | -216,370 |
| Employee Count | 25 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks. The beta is 2.92, so Burcon NutraScience's price volatility has been higher than the market average.
| Beta (5Y) | 2.92 |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 51.47 |
| Average Volume (20 Days) | 7,152 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Burcon NutraScience had revenue of 307,585 and -5.41 million in losses. Loss per share was -0.04.
| Revenue | 307,585 |
| Gross Profit | 152,473 |
| Operating Income | -5.12M |
| Pretax Income | -5.47M |
| Net Income | -5.41M |
| EBITDA | -4.91M |
| EBIT | -5.12M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 1.58 million in cash and 4.79 million in debt, giving a net cash position of -3.21 million.
| Cash & Cash Equivalents | 1.58M |
| Total Debt | 4.79M |
| Net Cash | -3.21M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.55M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.84M |
Cash Flow
In the last 12 months, operating cash flow was -4.67 million and capital expenditures -203,715, giving a free cash flow of -4.88 million.
| Operating Cash Flow | -4.67M |
| Capital Expenditures | -203,715 |
| Free Cash Flow | -4.88M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 49.57% |
| Operating Margin | -1,664.96% |
| Pretax Margin | -1,777.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,585.38% |
Dividends & Yields
Burcon NutraScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.72% |
| Shareholder Yield | -15.72% |
| Earnings Yield | -31.09% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Burcon NutraScience has an Altman Z-Score of -18.74. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.74 |
| Piotroski F-Score | n/a |